Aura Health Completes Name Change to Pharmadrug Inc

Aura Health (CSE: BUZZ) announced this morning that it has completed its name change to that of Pharmadrug Inc. The name change is intended to better reflect the operations of the firm, whom is focused on importing quality medical cannabis to the German and other European markets.

The name change, which was proposed earlier this year via a circular issued to shareholders, was approved on October 3 at an annual and special meeting of shareholders. The change reflects Aura’s 80% purchase of Pharmadrug Production GmbH this past may, a firm with the necessary narcotics licensing to import cannabis and other medical products to the German state.

We are consistently working to further develop our distribution of medical cannabis in Germany. In addition to the continued expansion of volumes from The Netherlands Office of Medicinal Cannabis, we are to launch our own proprietary brand with the introduction of Israeli-sourced supply in the second half of 2020. The company also expects upcoming Canadian supply deals, which could lead to an earlier ramp and brand launch.

Daniel Cohen, CEO of Pharmadrug

Common shares of Aura Health held by shareholders will automatically exchange for shares of Pharmadrug, without investors being required to take any action. There was no indication by the firm that the associated ticker would be changing.

Aura Health, now Pharmadrug, closed Friday’s session at $0.04.


FULL DISCLOSURE: Pharmadrug is a client of Canacom Group, the parent company of The Deep Dive. The author has been compensated to cover Pharmadrug on The Deep Dive, with The Deep Dive having full editorial control. Not a recommendation to buy or sell. Always do additional research and consult a professional before purchasing a security.

Video Articles

The Goal is Gold Production as Soon as Possible! | Gordon Robb – ESGOLD Corp.

Snowline Gold: The Multi Billion Dollar Valley PEA

Euro Sun: Rovina Copper-Gold Project Secures Some Major Funding

Recommended

Antimony Resources Drills 4.17% Antimony Over 7.4 Metres At Bald Hill

ESGold To Expand Mine Building At Montauban In Advance Of Gold & Silver Production

Related News

[PODCAST] Aura Health’s CEO Daniel Cohen on the German Opportunity

Aura Health Inc (CSE: BUZZ) recently sat down with Pat Beechinor of The Newswire to...

Wednesday, July 31, 2019, 11:34:39 AM

PharmaDrug’s Sairiyo To Begin Manufacturing PD-001 For Clinical Trials In Q2

PharmaDrug (CSE: PHRX) has seen its joint venture with PharmaTher Holdings (CSE: PHRM) begin to...
Wednesday, February 14, 2024, 09:46:59 AM

Canadian PubCo’s & The German Medical Cannabis Market

When it comes to federally legal market opportunities, it’s widely accepted that Europe is the...

Wednesday, May 29, 2019, 07:00:31 AM

Aura Health: The German Cannabis Play

The German medical cannabis market is estimated to reach $1.6 billion in sales by 2022...

Monday, July 15, 2019, 07:00:06 AM

PharmaDrug Names Dr David Kideckel As Chairman, While SecureDose Finalizes Formulation

PharmaDrug (CSE: PHRX) this morning released a series of updates, headlined by the appointment of...
Tuesday, February 27, 2024, 09:44:15 AM